VolitionRX (VNRX) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for VolitionRX
Is VolitionRX a buy right now? The alternative data says hold. This VNRX stock analysis is built on the 25+ alternative data signals AltIndex tracks on VolitionRX every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 45/100: a Hold. The stock trades at $0.21 with a $6M market cap.
The soft spots over the past 90 days: web traffic down 43.0% to 21K monthly visits, and headcount (according to LinkedIn) down 6.3% to 75 employees. The rest of the signal set is holding steady, which keeps VNRX at a hold rather than a sell.
VNRX’s broader alt-data profile also covers business outlook (61% of employees positive), Facebook followers (2K), and sentiment (100/100). Every signal links to its own page with full history, the VNRX technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on VNRX is just below.
VolitionRX AI Stock Analysis
VolitionRX (NYSE: VNRX) is a biotechnology company focused on developing simple, easy-to-use, blood-based diagnostic tests for cancer and other serious diseases. Leveraging its proprietary Nucleosomics® technology, the company seeks to provide early detection assays that can identify various types of cancer, including colorectal, pancreatic, and lung cancer.
Analysis generated October 4, 2026.
Recent VolitionRX Stock Alerts
|
VolitionRX | October 7 Price is down by -6.6% in the last 24h. |
|
VolitionRX | October 6 Price is up by 6% in the last 24h. |
|
VolitionRX | October 1 Price is down by -6.4% in the last 24h. |
|
VolitionRX | September 28 Price is down by -6.3% in the last 24h. |
VolitionRX Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 21K | 43.0% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 75 | 6.3% | |
| Employee Recommend | 100 | 0% | |
| Business Outlook | 61 | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 6 | 500.0% | |
| Stocktwits Mentions | 9 | 80.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 2K | 16.7% | |
| X Followers | 1K | 0% | |
| Facebook Followers | 2K | 0% | |
| Facebook Engagement | 0 | N/A |
About VolitionRX (VNRX)
VolitionRx Limited, a multinational epigenetics company, is dedicated to developing blood tests to help diagnose a variety of cancers and other diseases globally. The company is headquartered in Austin, Texas.
| Price | $0.21 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $6M |
| Year Range | $0 – $9 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest VolitionRX News
View more → |
Lateral Flow Assay Market to Reach US$ 16.37 Bn by 2031, Growing at 8.2% CAGR: New Report by Wissen ResearchSeptember 22 - PRNewswire |
 |
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in FranceSeptember 17 - PRNewswire |
 |
VolitionRx Participates in Launch of DETECSEPS Program in FranceSeptember 17 - PRNewswire |
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027September 14 - PRNewswire |
|
Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP ConferenceSeptember 10 - PRNewswire |
|
See VolitionRX’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for VNRX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEVolitionRX Earnings & Financial Performance
View all earnings →VolitionRX Insider Trading Activity
View all →| Reynolds Cameron John filed to sell 2,554,847 shares at $0.0. Nov 17 '25 |
| STILL TIMOTHY I filed to sell 48,076 shares at $0.0. Oct 14 '25 |
| Innes Guy Archibald filed to sell 96,153 shares at $0.0. Oct 14 '25 |
| Reynolds Cameron John filed to sell 110,000 shares at $0.0. Oct 14 '25 |
| Reynolds Cameron John filed to sell 2,624,847 shares at $0.0. Sep 12 '25 |
VolitionRX Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to VolitionRX
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
enVVeno MedicalNVNO |
$8.49 3.0% | $6M | 48 |
 |
Trinity BiotechTRIB |
$7.34 7.1% | $6M | 38 |
 |
Vivos TherapeuticsVVOS |
$0.15 2.4% | $5M | 48 |
 |
BiomericaBMRA |
$1.84 0.3% | $8M | 35 |
 |
Nexalin TechnologyNXL |
$3.51 3.3% | $4M | 41 |
Explore VolitionRX Data
Frequently Asked Questions: VolitionRX (VNRX)
VolitionRX has an AltIndex AI Score of 45/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
45/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of VolitionRX (VNRX) stock is $0.21 with a market cap of $6M.
As of today, VolitionRX’s PE (Price to Earnings) ratio is —.
View the latest VolitionRX insider transactions to see recent buying and selling activity by company executives and directors.
Check the VolitionRX congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The VNRX stock price chart above shows VolitionRX’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full VolitionRX technical analysis for RSI, moving averages, and more.
See the stocks similar to VolitionRX section on this page for companies in the same industry ranked by market cap and AI Score.
